Submitted by seekingalpha1903 in business
Pfizer cut revenue targets by $9B due to lower-than-expected sales of its COVID vaccine. Read why investors should continue watching PFE stock from the sidelines.
Submitted by seekingalpha1903 in business
Pfizer cut revenue targets by $9B due to lower-than-expected sales of its COVID vaccine. Read why investors should continue watching PFE stock from the sidelines.